Dr. Jankowski is the Case Western Reserve University Associate Vice President for Technology Management. In this capacity, Dr. Jankowski leads the University’s commercialization efforts that stem from the morer than $300 million of research activity taking place at the CWRU and its affiliate institutions annually. Dr. Jankowski is very dedicated to CWRU’s translational efforts and holds leadership roles on the Coulter-CWRU Translation and Innovation Partnership, the Ohio BRCP Center: Targeted Nanoparticles for Imaging and Therapeutics and the School of Medicine High Throughput Screening Program.
In addition to Dr. Jankowski’s primary commercialization and translational activities, he sits on the CWRU Conflict of Interest Committee, the Ohio Technology Transfer Officers’ Council, and the UHCMC Research Committee. Dr. Jankowski also serves the University through his active board representation in several CWRU spinoff companies, including Great Lakes Pharmaceuticals, Interventional Imaging, Inc. and Neuros Medical. Previously, Dr. Jankowski was a commercialization officer in the Office of Innovations at the Cleveland Clinic Foundation (CCF), a Technology Analyst in the Environmental Technology Commercialization Center at the Battelle Memorial Institute, and a research assistant with the SUNY Research Foundation.
Dr. Jankowski holds a Ph.D. in Chemistry from the State University of New York’s College of Environmental Sciences, an M.B.A. from the Weatherhead School of Management and a dual B.S. in Chemical and Environmental Engineering Technologies from the University of Dayton.